Nelson Duran
Cp 6152
Campinas, SP 13083970, Brazil
Campinas, SP 13083970, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Graphene oxide nanoscaffold functionalized with adipose-derived mesenchymal stem cells and sildenafil promotes urethral stricture repair and tissue regeneration.
Journal: Tissue & cell
Published: June 14, 2025
Biosynthesis and Characterization of Silver Nanoparticles and Simvastatin Association in Titanium Biofilms.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 21, 2024
Clinical and immunohistochemical effects of OncoTherad (MRB-CFI-1) nanoimmunotherapy on SERBP1, HABP4, CD44 and Ki-67 in BCG-unresponsive non-muscle invasive bladder cancer.
Journal: Tissue & cell
Published: October 18, 2024
A novel serous ovarian carcinoma model induced by DMBA: Results from OncoTherad® (MRB-CFI-1) immunotherapy preclinical testing.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 01, 2024
Influence of sodium anhydroglucuronate on poly (di(ethylene glycol) methyl ether methacrylate) grafting onto isolated cellulose nanofibrils.
Journal: International journal of biological macromolecules
Published: September 05, 2024
Modulation of the tumor microenvironment in non-muscle-invasive bladder cancer by OncoTherad® (MRB-CFI-1) nanoimmunotherapy: effects on tumor-associated macrophages, tumor-infiltrating lymphocytes, and monoamine oxidases.
Journal: Medical oncology (Northwood, London, England)
Published: June 14, 2024
Data normalization of plasma miRNA profiling from patients with COVID-19.
Journal: Scientific reports
Published: June 13, 2024
Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection.
Journal: Scientific reports
Published: March 22, 2024
OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway.
Journal: International journal of molecular sciences
Published: November 08, 2023
Violacein improves vemurafenib response in melanoma spheroids.
Journal: Natural product research
Published: August 12, 2023
Last Updated: 09/26/2026